Mediroute: An open-source AI platform exposing global drug price disparities (github.com)

MediRoute has launched an open-source platform that enables users to compare global drug prices, check the legality of importing medications, and receive AI-driven recommendations tailored to their needs. By focusing on five major markets— the US, Canada, India, Singapore, and the UK— the platform exposes significant price disparities, such as the dramatic difference for Imatinib, which costs $9,800/month in the US and just $208/month in India. MediRoute serves as a crucial resource for patients lacking awareness of these variations and helps verify trustworthy suppliers alongside compliance information. The significance of MediRoute lies in its potential to democratize access to affordable medications and streamline the often complex process of sourcing them legally. Utilizing advanced technologies like AI from Anthropic's Claude, along with a modular architecture that can scale to meet future needs, MediRoute not only provides critical drug market intelligence but also tracks supplier certifications and monitors drug shortages. With plans to expand its catalog from 100 to 100,000 drugs and increase the number of supported countries and languages, the platform is poised to have a transformative impact on global health accessibility.